Results 31 to 40 of about 171 (86)

Guselkumab, Risankizumab, and Tildrakizumab in the Management of Psoriasis: A Review of the Real-World Evidence. [PDF]

Clin Cosmet Investig Dermatol, 2022
Ruggiero A, Picone V, Martora F, Fabbrocini G, Megna M.   +4 more
europepmc   +1 more source

The interplay of post-acute COVID-19 syndrome and aging: a biological, clinical and public health approach. [PDF]

Ageing Res Rev, 2022
Guaraldi G, Milic J, Cesari M, Leibovici L, Mandreoli F, Missier P, Rozzini R, Cattelan AM, Motta F, Mussini C, Cossarizza A.   +10 more
europepmc   +1 more source

Priorities in Cardio-Oncology Basic and Translational Science: GCOS 2023 Symposium Proceedings: <i>JACC: CardioOncology</i> State-of-the-Art Review. [PDF]

JACC CardioOncol, 2023
Salloum FN, Tocchetti CG, Ameri P, Ardehali H, Asnani A, de Boer RA, Burridge P, Cabrera JÁ, de Castro J, Córdoba R, Costa A, Dent S, Engelbertsen D, Fernández-Velasco M, Fradley M, Fuster JJ, Galán-Arriola C, García-Lunar I, Ghigo A, González-Neira A, Hirsch E, Ibáñez B, Kitsis RN, Konety S, Lyon AR, Martin P, Mauro AG, Mazo Vega MM, Meijers WC, Neilan TG, Rassaf T, Ricke-Hoch M, Sepulveda P, Thavendiranathan P, van der Meer P, Fuster V, Ky B, López-Fernández T, International Cardio-Oncology Society.   +38 more
europepmc   +1 more source

Effect of levothyroxine replacement therapy in patients with subclinical hypothyroidism and chronic heart failure: A systematic review. [PDF]

Front Endocrinol (Lausanne), 2022
Triggiani V, Cittadini A, Lisco G.
europepmc   +1 more source

Cefdinir and β-Lactamase Inhibitor Independent Efficacy Against Mycobacterium tuberculosis. [PDF]

Front Pharmacol, 2021
Srivastava S, Thomas T, Howe D, Malinga L, Raj P, Alffenaar JW, Gumbo T.   +6 more
europepmc   +1 more source

Retrosigmoidal placement of an active transcutaneous bone conduction implant: surgical and audiological perspectives in a multicentre study. [PDF]

Acta Otorhinolaryngol Ital, 2021
Canzi P, Avato I, Beltrame M, Bianchin G, Perotti M, Tribi L, Gioia B, Aprile F, Malpede S, Scribante A, Manfrin M, Benazzo M.   +11 more
europepmc   +1 more source

Patient-Reported Well-Being in Value-Based Routine Care in Psoriatic Disease Using Tildrakizumab: 2-Year Data of the Phase IV POSITIVE Study. [PDF]

Psoriasis (Auckl)
Mrowietz U, Sommer R, Reguiai Z, Gerdes S, Daudén E, Weger W, Maul JT, Naldi L, Ghislain PD, Laws PM, De Jong EMGJ, Mburu S, Koscielny V, Massana E, Sapena V, Domenech A, Kasujee I, Augustin M.   +17 more
europepmc   +1 more source

Tunnelling nanotube formation is driven by Eps8/IRSp53-dependent linear actin polymerization. [PDF]

EMBO J, 2023
Henderson JM, Ljubojevic N, Belian S, Chaze T, Castaneda D, Battistella A, Giai Gianetto Q, Matondo M, Descroix S, Bassereau P, Zurzolo C.   +10 more
europepmc   +1 more source

Burden to Partners of People with Psoriasis: Results from the FamilyPso International Study. [PDF]

Am J Clin Dermatol
Mrowietz U, Meyer C, Großschädl K, Weger W, Wolf P, Gooderham M, O'Toole A, Vender R, Gerdes S, Körber A, Bellinato F, Gisondi P, Bardazzi F, Sacchelli L, Zengarini C, Dauden E, Llamas-Velasco M, Santamaría C, Abalde T, Flórez Á, Salgado-Boquete L, Baskan EB, Solak SS, Hartmann A.   +23 more
europepmc   +1 more source

A Machine-learning Approach for the Assessment of the Proliferative Compartment of Solid Tumors on Hematoxylin-Eosin-Stained Sections. [PDF]

Cancers (Basel), 2020
Martino F, Varricchio S, Russo D, Merolla F, Ilardi G, Mascolo M, dell'Aversana GO, Califano L, Toscano G, Pietro G, Frucci M, Brancati N, Fraggetta F, Staibano S.   +13 more
europepmc   +1 more source